Callan Family Office, LLC Novartis Ag Transaction History
Callan Family Office, LLC
- $1.57 Trillion
- Q4 2024
A detailed history of Callan Family Office, LLC transactions in Novartis Ag stock. As of the latest transaction made, Callan Family Office, LLC holds 28,874 shares of NVS stock, worth $3.17 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
28,874
Previous 1,901
1418.88%
Holding current value
$3.17 Million
Previous $219 Million
1185.02%
% of portfolio
0.18%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,473Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.34 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.21 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$897 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$753 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$611 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $236B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...